UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Randomised clinical trial: the beneficial effects of VSL#3 in obese children with non‐alcoholic steatohepatitis

Alimentary pharmacology & therapeutics, 2014-06, Vol.39 (11), p.1276-1285

2014

Volltextzugriff (PDF)

Adiponectin and insulin resistance in early‐ and late‐onset pre‐eclampsia

BJOG : an international journal of obstetrics and gynaecology, 2006-11, Vol.113 (11), p.1264-1269

2006

Volltextzugriff (PDF)

First trimester serum PAPP-A and NGAL in the prediction of late-onset pre-eclampsia

Prenatal diagnosis, 2009-11, Vol.29 (11), p.1066-1068

2009

Volltextzugriff (PDF)

First trimester serum neutrophil gelatinase-associated lipocalin in gestational diabetes

Diabetic medicine, 2009-12, Vol.26 (12), p.1293-1295

2009

Volltextzugriff (PDF)

ADAM 12 and PAPP-A at 14-17 weeks' gestation as biomarkers of pre-eclampsia

Prenatal diagnosis, 2011-06, Vol.31 (6), p.602-604

2011

Volltextzugriff (PDF)

Placental growth hormone in Down's syndrome screening

The journal of maternal-fetal & neonatal medicine, 2004-10, Vol.16 (4), p.241-243

2004

Volltextzugriff (PDF)

FranceCoag: a 22-year prospective follow-up of the national French cohort of patients with inherited bleeding disorders

European journal of epidemiology, 2019-05, Vol.34 (5), p.521-532

2019

Volltextzugriff (PDF)

Urinary (1)H-NMR-based metabolic profiling of children with NAFLD undergoing VSL#3 treatment

International Journal of Obesity, 2015-07, Vol.39 (7), p.1118-1125

2015

Volltextzugriff (PDF)

Is mid-trimester maternal serum inhibin-A a marker of preeclampsia or intrauterine growth restriction?

Acta obstetricia et gynecologica Scandinavica, 2002-06, Vol.81 (6), p.540-543

2002

Volltextzugriff (PDF)

Urinary super(1)H-NMR-based metabolic profiling of children with NAFLD undergoing VSL#3 treatment

International Journal of Obesity, 2015-07, Vol.39 (7), p.1118-1125

2015

Volltextzugriff (PDF)

Urinary 1H-NMR-based metabolic profiling of children with NAFLD undergoing VSL#3 treatment

International Journal of Obesity, 2015-07, Vol.39 (7), p.1118-1125

2015

Volltextzugriff (PDF)

Urinary .sup.1H-NMR-based metabolic profiling of children with NAFLD undergoing VSL#3 treatment

International Journal of Obesity, 2015-07, Vol.39 (7), p.1118

2015

Volltextzugriff (PDF)

Neurokinin B peptide levels in normal pregnancy

European journal of obstetrics & gynecology and reproductive biology, 2002-06, Vol.103 (1), p.101-102

2002

Volltextzugriff (PDF)

Plasma adiponectin concentration in early pregnancy and subsequent risk of hypertensive disorders

Obstetrics and gynecology (New York. 1953), 2005-08, Vol.106 (2), p.340-344

2005

Volltextzugriff (PDF)

Are IL-31, IL-33, and PlGF candidate markers for Pre-eclampsia?

Obstetrics and Gynecology Reports, 2017, Vol.1 (3)

2017

Volltextzugriff (PDF)

The effect of the phytoestrogen genistein and hormone replacement therapy on homocysteine and C-reactive protein level in postmenopausal women

Acta obstetricia et gynecologica Scandinavica, 2005-05, Vol.84 (5), p.474-477

2005

Volltextzugriff (PDF)

The clinical utility of serum uric acid measurements in pre-eclampsia and transient hypertension in pregnancy

Panminerva medica, 2000-06, Vol.42 (2), p.101

2000

Volltextzugriff (PDF)

Plasma homocysteine in early and late pregnancies complicated with preeclampsia and isolated intrauterine growth restriction

Acta obstetricia et gynecologica Scandinavica, 2004-02, Vol.83 (2), p.155-158

2004

Volltextzugriff (PDF)

First trimester serum PAPP‐A and NGAL in the prediction of late‐onset pre‐eclampsia

Prenatal diagnosis, 2009-11, Vol.29 (11), p.1066-1068

2009

Volltextzugriff (PDF)

Neurokinin B and nitric oxide plasma levels in pre‐eclampsia and isolated intrauterine growth restriction

BJOG : an international journal of obstetrics and gynaecology, 2004-10, Vol.111 (10), p.1046-1050

2004

Volltextzugriff (PDF)

Endocrine changes in postmenopausal women after high-dose danazol therapy

Panminerva medica, 1999-06, Vol.41 (2), p.139

1999

Volltextzugriff (PDF)

C-reactive protein as an early predictor of gestational diabetes mellitus

Journal of reproductive medicine, 2006-01, Vol.51 (1), p.55

2006

Volltextzugriff (PDF)

Placental growth hormone in Down's syndrome screening

The journal of maternal-fetal & neonatal medicine, 2004-10, Vol.16 (4), p.241-243

2004

Volltextzugriff (PDF)

Prostate-specific antigen in prenatal screening for Down’s syndrome

European journal of obstetrics & gynecology and reproductive biology, 2001-06, Vol.96 (2), p.238-238

2001

Volltextzugriff (PDF)

Hormonal disregulation and catamenial epilepsy

Functional neurology, 1990-01, Vol.5 (1), p.49

1990

Volltextzugriff (PDF)

1 – 25 von 120

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(88)
Mit Volltextzugriff
(69)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(69)
Female
(58)
Science & Technology
(52)
Life Sciences & Biomedicine
(51)
Adult
(33)
Biological And Medical Sciences
(28)
Male
(28)
Medical Sciences
(25)
Middle Aged
(22)
Aged
(19)
Pregnancy
(19)
Obstetrics & Gynecology
(12)
Gynecology. Andrology. Obstetrics
(11)
Fundamental And Applied Biological Sciences. Psychology
(9)
Case-Control Studies
(8)
Pre-Eclampsia - Blood
(8)
Adolescent
(7)
Animals
(7)
Child
(6)
Double-Blind Method
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Randomised clinical trial: the beneficial effects of VSL#3 in obese children with non‐alcoholic steatohepatitis

Adiponectin and insulin resistance in early‐ and late‐onset pre‐eclampsia

First trimester serum PAPP-A and NGAL in the prediction of late-onset pre-eclampsia

First trimester serum neutrophil gelatinase-associated lipocalin in gestational diabetes

ADAM 12 and PAPP-A at 14-17 weeks' gestation as biomarkers of pre-eclampsia

Placental growth hormone in Down's syndrome screening

FranceCoag: a 22-year prospective follow-up of the national French cohort of patients with inherited bleeding disorders

Urinary (1)H-NMR-based metabolic profiling of children with NAFLD undergoing VSL#3 treatment

Is mid-trimester maternal serum inhibin-A a marker of preeclampsia or intrauterine growth restriction?

Urinary super(1)H-NMR-based metabolic profiling of children with NAFLD undergoing VSL#3 treatment

Urinary 1H-NMR-based metabolic profiling of children with NAFLD undergoing VSL#3 treatment

Urinary .sup.1H-NMR-based metabolic profiling of children with NAFLD undergoing VSL#3 treatment

Neurokinin B peptide levels in normal pregnancy

Plasma adiponectin concentration in early pregnancy and subsequent risk of hypertensive disorders

Are IL-31, IL-33, and PlGF candidate markers for Pre-eclampsia?

The effect of the phytoestrogen genistein and hormone replacement therapy on homocysteine and C-reactive protein level in postmenopausal women

The clinical utility of serum uric acid measurements in pre-eclampsia and transient hypertension in pregnancy

Plasma homocysteine in early and late pregnancies complicated with preeclampsia and isolated intrauterine growth restriction

First trimester serum PAPP‐A and NGAL in the prediction of late‐onset pre‐eclampsia

Neurokinin B and nitric oxide plasma levels in pre‐eclampsia and isolated intrauterine growth restriction

Endocrine changes in postmenopausal women after high-dose danazol therapy

C-reactive protein as an early predictor of gestational diabetes mellitus

Placental growth hormone in Down's syndrome screening

Prostate-specific antigen in prenatal screening for Down’s syndrome

Hormonal disregulation and catamenial epilepsy

Suchergebnisse filtern